Poolbeg Pharma (POLB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

10.60p
   
  • Change Today:
      0.25p
  • 52 Week High: 11.50
  • 52 Week Low: 6.55
  • Currency: UK Pounds
  • Shares Issued: 500.00m
  • Volume: 1,368,085
  • Market Cap: £53.00m

Latest Deals

Traded Action Notifier PriceAmountValue
21-Feb-24 Buy Jeremy Skillington 10.80p 154,764 £16,714.51
19-Feb-24 Buy Cathal Friel 11.68p 830,000 £96,944.00

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
19-Feb-24 Buy Cathal Friel 11.68p 830,000 £96,944.00
21-Feb-24 Buy Jeremy Skillington 10.80p 154,764 £16,714.51

Director Shareholdings

Notifier Holding Value*
Cathal Friel 37,219,757 £3,945,294
Ian O’Connel 8,326,839 £882,645
Jeremy Skillington 1,028,261 £108,996

Major Shareholders

Notifier** Holding Value*
Schroder Investment Management 24,994,777 £2,649,446
Michael Kelly 18,168,127 £1,925,822

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Poolbeg Pharma Market Data

Currency UK Pounds
Share Price 10.60p
Change Today 0.25p
% Change 2.42 %
52 Week High 11.50
52 Week Low 6.55
Volume 1,368,085
Shares Issued 500.00m
Market Cap £53.00m

Poolbeg Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
61.29% below the market average61.29% below the market average61.29% below the market average61.29% below the market average61.29% below the market average
47.17% below the sector average47.17% below the sector average47.17% below the sector average47.17% below the sector average47.17% below the sector average
Price Trend
93.93% above the market average93.93% above the market average93.93% above the market average93.93% above the market average93.93% above the market average
96.49% above the sector average96.49% above the sector average96.49% above the sector average96.49% above the sector average96.49% above the sector average
Income Not Available
Growth Not Available

Poolbeg Pharma Dividends

No dividends found

Trades for 19-Apr-2024

Time Volume / Share Price
16:24 130,000 @ 10.50p
16:21 40,682 @ 10.50p
15:56 1,968 @ 10.50p
15:54 30,000 @ 10.60p
15:36 234 @ 10.67p

Poolbeg Pharma Key Personnel

CEO Jeremy Skillington
CFO Ian O’Connel

Top of Page